Related Experiment Video
Updated: May 14, 2026

10:02
A Battery of Motor Tests in a Neonatal Mouse Model of Cerebral Palsy
Published on: November 3, 2016
Pediatric Guillain-Barré Syndrome
1Division of Neurology, Akron Children's Hospital, Akron, Ohio, USA.
Muscle & Nerve
|May 13, 2026
Summary
Guillain-Barré syndrome (GBS) in children presents uniquely, often with nonspecific symptoms delaying diagnosis. Early recognition of these pediatric-specific features is crucial for effective management and favorable outcomes.
Area of Science:
- Pediatric Neurology
- Neuroimmunology
Background:
- Guillain-Barré syndrome (GBS) is a primary cause of acute flaccid paralysis in children.
- Pediatric GBS exhibits distinct clinical features compared to adult GBS, impacting diagnosis and management.
Purpose of the Study:
- To highlight the pediatric-specific nuances of GBS presentation, diagnosis, and management.
- To emphasize the importance of recognizing atypical symptoms and diagnostic challenges in children.
Main Methods:
- Review of clinical features, diagnostic approaches, and treatment strategies for pediatric GBS.
- Comparison of pediatric GBS with adult GBS and other potential etiologies.
Main Results:
- Pediatric GBS often presents with nonspecific symptoms like pain or irritability preceding weakness, leading to diagnostic delays.
- Diagnostic evaluations in children can be challenging, sometimes requiring sedation for procedures like electrodiagnostic testing or lumbar puncture.
- Spinal MRI with gadolinium can aid diagnosis and rule out other conditions. Intravenous immunoglobulin is the primary treatment, with plasma exchange used less frequently.
Conclusions:
- Timely diagnosis and management of pediatric GBS require awareness of its unique presentation and diagnostic hurdles.
- While outcomes are generally good, disease severity and supportive care influence prognosis.
- Acute-onset chronic inflammatory demyelinating polyradiculoneuropathy is a key differential diagnosis requiring longitudinal assessment.
Related Concept Videos
Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
